anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sparkline

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 22,963
Current window 13,201-13,230
Pages 766
Rows per page 30
Arc: Sparklineclear collectionreset all
18 30 60

Arc

13,201-13,230 of 22,963

filter-aware
01
Slide 1
The slide uses Python-like code snippets to illustrate the technical nature of their drug discovery platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Setup1 hit
02
Includes code snippets as decorative background elements.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Setup1 hit
03
Absci | Investor Presentation Deck | 27 slidesAbsci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Setup1 hit
04
Absci | Investor Presentation Deck | 27 slidesAbsci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SetupLoop · Golden Circle1 hit
05
The diagram illustrates the iterative, inefficient nature of conventional drug discovery (immunization/phage display) leading to suboptimal candidates.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a two-column bulleted list to contrast the general AI drug discovery market with Absci's specific focus on biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a two-column bulleted list to contrast traditional methods with their AI-driven approach and the resulting benefits.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide features a background image of scientists at a whiteboard with technical diagrams and code snippets, reinforcing the 'drug creation' theme.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a metaphor of 'creating the needle' rather than 'finding it in a haystack' to describe their AI-driven drug design process.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide highlights six specific parameters: Target, Affinity, Epitope, Developability, Manufacturability, and Immunogenicity.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses a circular process diagram to represent the flywheel effect of their platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
12
Uses a comparison framework to contrast data availability between small molecules and biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
13
The slide uses a process flow diagram to illustrate the transition from biological wet-lab data generation to AI model training.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
14
The slide uses a linear process flow to demonstrate the end-to-end nature of the platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
The diagram is a circular flywheel process showing the integration of data, wet lab validation, and AI creation.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
16
Includes code snippet in top-left and historical clinical trial approval data in top-right as context.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
17
The slide illustrates a process flow from target antigen/epitope to AI-generated antibody scaffold, followed by wet lab validation (ACE/SPR assays) to identify binders.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
18
The slide uses a four-column layout to categorize value propositions, each supported by a visual icon or diagram.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
19
Uses a timeline comparison to illustrate value proposition.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
20
The chart uses a dot-plot visualization to represent cash flow magnitude over time, categorized by development stages.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
21
The slide uses a table-like layout to present key company metrics as evidence of market readiness.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
22
Uses quotes from partner executives to establish credibility.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ActionLoop · Before After1 hit
23
The slide highlights the strategic shift towards internal asset development alongside existing partnerships, emphasizing the credibility of the team.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
23
The slide uses a comparison matrix structure to contrast debt instruments.Oatly | Results Presentation Deck | 37 slides · Oatly
Conference presentation Investor relations Beat · Resolution1 hit
24
The slide uses a chevron-style flow to connect 2023 targets to the 2024 EBITDA goal.Oatly | Results Presentation Deck | 37 slides · Oatly
Conference presentation Investor relations Beat · ResolutionLoop · Quick Win Big Bet1 hit
25
The chart shows a bridge from ~16% to high 20s% margin.Oatly | Results Presentation Deck | 37 slides · Oatly
Conference presentation Investor relations Beat · Resolution1 hit
26
Includes a footnote regarding non-IFRS measures.Oatly | Results Presentation Deck | 37 slides · Oatly
Conference presentation Investor relations Beat · Resolution1 hit
01
Slide 1
Signature Bank | Results Presentation Deck | 3 slidesSignature Bank | Results Presentation Deck | 3 slides · Signature Bank
Conference presentation Investor relations Beat · Setup1 hit
02
The slide provides specific figures regarding deposit and loan balance fluctuations, specifically highlighting the reduction in digital asset client deposits.Signature Bank | Results Presentation Deck | 3 slides · Signature Bank
Conference presentation Investor relations Beat · Evidence1 hit
03
Signature Bank | Results Presentation Deck | 3 slidesSignature Bank | Results Presentation Deck | 3 slides · Signature Bank
Conference presentation Investor relations Beat · Resolution1 hit